|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | |||||||||||
| Cash and cash equivalents | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Noncurrent assets: | |||||||||||
| Property and equipment, net | |||||||||||
| Deferred offering costs | |||||||||||
| Total noncurrent assets | |||||||||||
| Total Assets | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | |||||||||||
| Short term debt - convertible notes, net of unamortized debt discount | |||||||||||
| Accrued expenses | |||||||||||
| Total current liabilities | |||||||||||
| Warrant liability | |||||||||||
| Long term debt - convertible notes, net of unamortized debt discount | |||||||||||
| Long term debt - convertible notes, net of unamortized debt discount | |||||||||||
| Total Liabilities | |||||||||||
| Stockholders' equity: | |||||||||||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively | |||||||||||
| Common stock, $0.001 par value, 500,000,000 shares authorized, 542,312 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total Stockholders' Equity | |||||||||||
| Total Liabilities and Stockholders' Equity |
Loading...
